• 1. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzodioxoles Benzodioxoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzodioxoles

Chemical Profile of 5-(2-Bromoethyl)-1,3-benzodioxole (CAS No. 57587-02-7)

5-(2-Bromoethyl)-1,3-benzodioxole, identified by the Chemical Abstracts Service Number (CAS No.) 57587-02-7, is a significant compound in the realm of organic chemistry and pharmaceutical research. This heterocyclic aromatic ether features a unique structural framework that has garnered considerable attention from the scientific community due to its potential applications in medicinal chemistry and synthetic organic transformations. The compound's molecular structure consists of a benzodioxole core substituted with a 2-bromoethyl side chain, which imparts distinct reactivity and functionalization possibilities. This introduction delves into the chemical properties, synthesis methodologies, and emerging applications of 5-(2-Bromoethyl)-1,3-benzodioxole, emphasizing its relevance in contemporary research.

The benzodioxole moiety, also known as 1,3-dioxolo[4,5-c]benzene, is a prominent scaffold in natural products and pharmaceuticals, renowned for its biological activity and structural versatility. The introduction of a 2-bromoethyl group at the 5-position of the benzodioxole ring enhances its utility as a synthetic intermediate. The bromine atom serves as a versatile handle for further functionalization via cross-coupling reactions such as Suzuki-Miyaura, Heck, and Buchwald-Hartwig couplings. These transformations are pivotal in constructing complex molecular architectures, making 5-(2-Bromoethyl)-1,3-benzodioxole a valuable building block for drug discovery programs.

From a synthetic perspective, the preparation of 5-(2-Bromoethyl)-1,3-benzodioxole can be achieved through multiple pathways. One common approach involves the bromination of 1,3-dihydroxybenzene (resorcinol) followed by alkylation with 2-bromoethanol under controlled conditions. Alternatively, palladium-catalyzed cross-coupling reactions between halogenated benzodioxoles and 2-bromoethane derivatives offer a more direct route to the target compound. The choice of synthetic method depends on factors such as yield optimization, scalability, and purity requirements. Recent advancements in catalytic systems have improved the efficiency of these reactions, enabling higher selectivity and reduced byproduct formation.

The pharmacological potential of 5-(2-Bromoethyl)-1,3-benzodioxole has been explored in several research studies. Its structural motif is reminiscent of well-known bioactive compounds, suggesting possible interactions with biological targets such as enzymes and receptors. Preliminary in vitro studies have indicated that derivatives of this compound exhibit moderate activity against certain enzymatic pathways relevant to inflammatory diseases and cancer. The 2-bromoethyl substituent plays a crucial role in modulating these interactions by influencing electronic properties and steric hindrance around the benzodioxole core. Further investigation is warranted to fully elucidate its therapeutic profile.

In the context of medicinal chemistry innovation, 5-(2-Bromoethyl)-1,3-benzodioxole serves as a versatile scaffold for structure-activity relationship (SAR) studies. By systematically modifying substituents on the benzodioxole ring or the 2-bromoethyl side chain, researchers can fine-tune pharmacological properties such as potency, selectivity, and metabolic stability. This approach has been instrumental in developing novel therapeutic agents with improved pharmacokinetic profiles. The compound's compatibility with modern drug discovery tools makes it an attractive candidate for high-throughput screening (HTS) campaigns aimed at identifying lead compounds for unmet medical needs.

The role of computational chemistry in optimizing derivatives of 5-(2-Bromoethyl)-1,3-benzodioxole cannot be overstated. Molecular modeling techniques allow researchers to predict binding affinities and optimize virtual libraries of analogs before conducting experimental synthesis. These computational methods leverage quantum mechanical calculations and machine learning algorithms to accelerate drug development pipelines. By integrating experimental data with computational insights, scientists can design more effective derivatives with enhanced biological activity while minimizing off-target effects.

Emerging applications of 5-(2-Bromoethyl)-1,3-benzodioxole extend beyond traditional pharmaceuticals into other areas such as materials science and agrochemicals. Its ability to undergo diverse chemical transformations makes it suitable for synthesizing polymers with tailored properties or functionalized ligands for catalysis. Additionally, modifications to its core structure have led to compounds with herbicidal or fungicidal activity under investigation for sustainable agriculture practices.

Future directions in research on 5-(2-Bromoethyl)-1,3-benzodioxole include exploring its role in developing next-generation therapeutics targeting neurological disorders and infectious diseases. The benzodioxole scaffold has shown promise in modulating neurotransmitter systems and antiviral pathways when appropriately functionalized. Collaborative efforts between academic institutions and pharmaceutical companies are essential to translate these findings into clinical applications that benefit patients worldwide.

In conclusion,5-(2-Bromoethyl)-1,3-benzodioxole (CAS No. 57587-02-7) is a multifaceted compound with significant potential across multiple domains of chemical research. Its unique structural features enable diverse synthetic strategies while offering opportunities for developing novel bioactive molecules through medicinal chemistry innovation。 As our understanding of its properties continues to evolve， so too will its applications in medicine， materials science，and beyond。

• 84598-13-0(1,3-Benzodioxole, 5-(phenylmethyl)-)
• 197805-26-8( )
• 60373-70-8(3,4-(Methylenedioxy)ethylbenzene)
• 40173-90-8(3,4-Dimethoxyphenethyl Bromide)
• 108303-53-3(1,3-Benzodioxole,5-(1-methylethyl)-)
• 5458-11-7(5-(2,3-dibromopropyl)-1,3-benzodioxole)
• 5463-71-8(5-(2-bromopropyl)-1,3-dioxaindane)
• 105591-45-5(5-(2-bromopropyl)-6-methoxy-1,3-dioxaindane)
• 105591-41-1(1,3-Benzodioxole, 4-(2-bromopropyl)-5,6,7-trimethoxy-)
• 65495-26-3(5-(2-bromoethyl)-1,2,3-trimethoxybenzene)